ArticlePathogens (Basel, Switzerland)2022
Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 20 citations in OpenAlex.
- Structural transition in antimicrobial resistance dynamics ofInfectious Disease Modelling · 2027Article
- Multidrug-resistant Corynebacterium striatum-induced severe pneumonia complicated with multiple organ failure: a diagnostic breakthrough guided by phagocytosis and therapeutic strategy.BMC infectious diseases · 2026Article
- Phenotypic-genotypic characteristics of Corynebacterium striatum clinical isolates and diversified biofilm production capabilities in the presence of plasma proteins.BMC microbiology · 2026Article
- Genomic and clinical insights into multidrug-resistantFrontiers in microbiology · 2026Article
- Article
- Relapsing peritoneal dialysis-associated peritonitis caused by Corynebacterium striatum: a case report.CEN case reports · 2025Article
- Metagenomic next-generation sequencing for the diagnosis of Corynebacterium striatum meningitis: case report and literature review.BMC neurology · 2025Review
- Corynebacterium Striatum Infective Endocarditis: A Systematic Review.Journal of inflammation research · 2025Review
- Clinical Characteristics and Risk Factors ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025Article
- Article
- Case Report: From lung to peritoneum: genomic and immunologic insights into a rare dual-siteFrontiers in immunology · 2025Article
- Contribution of the Mobilome to the Configuration of the Resistome ofInternational journal of molecular sciences · 2024Article
- Article
- Rising prevalence and drug resistance ofFrontiers in cellular and infection microbiology · 2024Review
- Isolation and identification of a novel phage targeting clinical multidrug-resistantFrontiers in cellular and infection microbiology · 2024Article
- Prescription of Rifampicin forPathogens (Basel, Switzerland) · 2023Article
- Identification and Evolutionary Relationship ofPathogens (Basel, Switzerland) · 2022Article
- 'Targeting' the search: An upgraded structural and functional repository of antimicrobial peptides for biofilm studies (B-AMP v2.0) with a focus on biofilm protein targets.Frontiers in cellular and infection microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The role of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.